Portal Biotech

Portal Biotech

Private
LondonHealthcare & Life Scienceshttps://www.portalbiotech.com/

Last Round

Series A

Jun 30, 2025

Total Funding Raised

$45.59M

Company Overview

Portal Biotech is a biotechnology company developing a platform for full-length, single-molecule protein sequencing using nanopore technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

protein sequencingnanopore sequencingproteomicsnext-gen proteomicssingle-molecule sequencingfull-length protein sequencingbenchtop instrumentsdrug discoverybiosecuritybiodefensedual-use technologylife sciences instrumentationdiagnosticsAI for drug discoverypeptide spectrometryNPS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Portal Biotech Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Portal Biotech Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJun 30, 2025
SeedJul 15, 2022
Pre SeedJul 16, 2021

Portal Biotech Investors

Notable investors and investment history

InvestorRounds
SCVCSeries A, Seed, Pre Seed
We Venture CapitalSeries A
British Business BankSeries A
Amino CollectiveSeed, Series A
NATO Innovation FundSeries A
Pillar VCSeries A, Seed
Earlybird Venture CapitalSeries A

Portal Biotech Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Portal Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Portal Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Year Founded2021
Last FundingJun 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.